Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-16

FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for amphetamine sulfate manufactured by Aurolife Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphetamine sulfate (amphetamine sulfate)

Snippet

SUPPL AP for AMPHETAMINE SULFATE (AMPHETAMINE SULFATE)